Skip to Content

1,417 Results Found

  • Article
  • Open Access
7 Citations
2,801 Views
10 Pages

Rationally Designed Oral DOX Gels for Colon-Specific Administration

  • Jie Li,
  • Luping Ma,
  • Cheng Wang,
  • Pengju Jiang and ,
  • Pengfei Cui and
  • Jianhao Wang
  • + 1 author+ 0 author

22 November 2022

Colorectal cancer (CRC) is the third leading cause of death from cancer in both men and women. Traditional CRC dosage forms deliver the drug to both desired and unwanted sites of drug action, resulting in a number of negative side effects. Chemothera...

(This article belongs to the Section Gel Applications)
  • Article
  • Open Access
18 Citations
6,345 Views
16 Pages

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways

  • Zaid H. Maayah,
  • Ti Zhang,
  • Marcus Laird Forrest,
  • Samaa Alrushaid and ,
  • Michael R. Doschak,
  • Neal M. Davies and
  • Ayman O. S. El-Kadi
  • + 2 authors+ 0 author

Doxorubicin (DOX) is a very potent and effective anticancer agent. However, the effectiveness of DOX in osteosarcoma is usually limited by the acquired drug resistance. Recently, Vitamin D (Vit-D) was shown to suppress the growth of many human cancer...

(This article belongs to the Special Issue Drug Delivery Technology Development in Canada)
  • Article
  • Open Access
40 Citations
13,760 Views
14 Pages

Doxing: What Adolescents Look for and Their Intentions

  • Mengtong Chen,
  • Anne Shann Yue Cheung and
  • Ko Ling Chan

Doxing is a form of cyberbullying in which personal information on others is sought and released, thereby violating their privacy and facilitating further harassment. This study examined adolescents’ doxing participation using a representative...

(This article belongs to the Special Issue Child Victimisation)
  • Article
  • Open Access
11 Citations
3,136 Views
14 Pages

Facile Synthesis of Fe3O4@Au/PPy-DOX Nanoplatform with Enhanced Glutathione Depletion and Controllable Drug Delivery for Enhanced Cancer Therapeutic Efficacy

  • Chunxia Qi,
  • Wanni Wang,
  • Peisan Wang,
  • Hanlong Cheng and ,
  • Xueyan Wang,
  • Baoyou Gong,
  • Anjian Xie and
  • Yuhua Shen
  • + 3 authors+ 0 author

22 June 2022

The complex physiological environment and inherent self-healing function of tumors make it difficult to eliminate malignant tumors by single therapy. In order to enhance the efficacy of antitumor therapy, it is significant and challenging to realize...

  • Article
  • Open Access
25 Citations
8,842 Views
8 Pages

Doxing is the searching for and intentional disclosure of private information about a particular individual on the Internet without his or her consent, and is often used to exact punishment. The aim of this study was to investigate the associations b...

(This article belongs to the Special Issue Child Victimisation)
  • Article
  • Open Access
2 Citations
4,138 Views
14 Pages

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma

  • Britt Van Renterghem,
  • Agnieszka Wozniak,
  • Ludovica Tarantola,
  • Andrea Casazza and ,
  • Jasmien Wellens,
  • Madita Nysen,
  • Ulla Vanleeuw,
  • Che-Jui Lee,
  • Geert Reyns and
  • Patrick Schöffski
  • + 7 authors+ 2 authors

Despite poor response rates and dose-limiting cardiotoxicity, doxorubicin (doxo) remains the standard-of-care for patients with advanced soft tissue sarcoma. We evaluated the efficacy of two tetrapeptidic doxo prodrugs (PhAc-ALGP-Dox or CBR-049 and C...

(This article belongs to the Special Issue Pathogenic Mechanisms and Novel Therapeutic Approaches for Sarcomas)
  • Proceeding Paper
  • Open Access
1 Citations
2,007 Views
5 Pages

Novel TNBC-Targeted DOX-Arsonoliposomes

  • Maria Mantzari,
  • Foteini Gartziou,
  • Eleni Lambrou,
  • Spyridon Mourtas and ,
  • Paraskevi Zagana and
  • Sophia G. Antimisiaris
  • + 1 author+ 0 author

1 December 2020

Arsonoliposomes (ARSL) constitute a particular class of liposomes that incorporate arsonolipids (ARS) into their membranes. ARSL realize selective toxicity to cancer cells; thus, they are an important tool in the treatment of cancer. Folic acid (FA)...

(This article belongs to the Proceedings of The 1st International Electronic Conference on Pharmaceutics)
  • Article
  • Open Access
8 Citations
3,176 Views
15 Pages

Previous studies have reported substantial improvement of microbubble (MB)-mediated drug delivery with ultrasound when drugs are loaded onto the MB shell compared with a physical mixture. However, drug loading may affect shell properties that determi...

(This article belongs to the Special Issue Ultrasound-Aided Drug Delivery)
  • Review
  • Open Access
151 Citations
13,910 Views
17 Pages

Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis

  • Hiroki Kitakata,
  • Jin Endo,
  • Hidehiko Ikura,
  • Hidenori Moriyama and ,
  • Kohsuke Shirakawa,
  • Yoshinori Katsumata and
  • Motoaki Sano
  • + 2 authors+ 0 author

26 January 2022

Doxorubicin (DOX) is the most widely used anthracycline anticancer agent; however, its cardiotoxicity limits its clinical efficacy. Numerous studies have elucidated the mechanisms underlying DOX-induced cardiotoxicity, wherein apoptosis has been repo...

(This article belongs to the Special Issue Metabolic Therapies for Heart Failure)
  • Article
  • Open Access
1 Citations
545 Views
17 Pages

PLLA@PDA-DOX Nanobubbles for Ultrasound Imaging Combined Chemo-Photothermal Therapy

  • Jie Zhang,
  • Xinyi Li,
  • Huiming Zhang,
  • Mingzhong Wu and ,
  • Baoqing Gao,
  • Da Zhang and
  • Hongyun Cui
  • + 2 authors+ 0 author

The photothermal conversion capability of polydopamine (PDA) was exploited to load the anticancer drug doxorubicin (DOX) onto its surface via π-π stacking and hydrogen-bond interactions, yielding a PDA-DOX complex. In this study, biocompatible...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
17 Citations
5,481 Views
22 Pages

LC-MS/MS Proteomic Study of MCF-7 Cell Treated with Dox and Dox-Loaded Calcium Carbonate Nanoparticles Revealed Changes in Proteins Related to Glycolysis, Actin Signalling, and Energy Metabolism

  • Hamidu Ahmed,
  • Mokrish Ajat,
  • Rana I. Mahmood,
  • Rozaihan Mansor and ,
  • Intan Shameha Abdul Razak,
  • Jameel R. Al-Obaidi,
  • Nurhanani Razali,
  • Alhaji Zubair Jaji,
  • Abubakar Danmaigoro and
  • Md Zuki Abu Bakar
  • + 5 authors+ 0 author

13 September 2021

One of the most prevalent death causes among women worldwide is breast cancer. This study aimed to characterise and differentiate the proteomics profiles of breast cancer cell lines treated with Doxorubicin (DOX) and Doxorubicin-CaCO3-nanoparticles (...

(This article belongs to the Special Issue Extracellular Vesicles: Multifaceted Biological Nanoparticles in Health and Disease)
  • Article
  • Open Access
1 Citations
843 Views
20 Pages

Preparation of PSA-DOX/ICG-Lip and Evaluation of Its Efficacy Against Cervical Cancer

  • Jingya Bai,
  • Jiamin Huang,
  • Qian Zhang,
  • Wenjun Su and ,
  • Xiaohui Tang,
  • Mukadaisi Amuti,
  • Guorui Zhu,
  • Qi Shen,
  • Jian Yang and
  • Mei Wang
  • + 5 authors+ 0 author

Objectives: To fabricate polysialic acid (PSA)-modified liposomes co-loaded with doxorubicin (DOX) and indocyanine green (ICG) for synergistic chemotherapy and photothermal therapy, and to enhance the anti-cervical cancer efficacy of liposomes via ne...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
15 Citations
4,481 Views
19 Pages

Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity

  • Zhuoyue Li,
  • Jingru Wang,
  • Junwei Liu,
  • Jianming Yu and ,
  • Jingwen Wang,
  • Hui Wang,
  • Qingchao Wei,
  • Man Liu,
  • Meiqi Xu and
  • Xuan Zhang
  • + 7 authors+ 2 authors

Multifunctional nanoparticles are of significant importance for synergistic multimodal antitumor activity. Herein, zinc oxide (ZnO) was used as pH-sensitive nanoparticles for loading the chemotherapy agent doxorubicin (DOX) and the photosensitizer ag...

(This article belongs to the Special Issue Nanostructured Materials/Biomaterials for Healthcare Applications)
  • Article
  • Open Access
23 Citations
4,705 Views
14 Pages

Mollification of Doxorubicin (DOX)-Mediated Cardiotoxicity Using Conjugated Chitosan Nanoparticles with Supplementation of Propionic Acid

  • Durairaj Siva,
  • Subramanian Abinaya,
  • Durairaj Rajesh,
  • Govindaraju Archunan and ,
  • Parasuraman Padmanabhan,
  • Balázs Gulyás and
  • Shanmugam Achiraman
  • + 2 authors+ 0 author

31 January 2022

Doxorubicin is an extensively prescribed antineoplastic agent. It is also known for adverse effects, among which cardiotoxicity tops the list. The possible mechanism underlying doxorubicin (DOX)-mediated cardiotoxicity has been investigated in this s...

(This article belongs to the Special Issue Nanotechnology-Based Diagnostics)
  • Article
  • Open Access
40 Citations
5,018 Views
14 Pages

Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway

  • Jung Joo Yoon,
  • Chan Ok Son,
  • Hye Yoom Kim,
  • Byung Hyuk Han and ,
  • Yun Jung Lee,
  • Ho Sub Lee and
  • Dae Gill Kang
  • + 2 authors+ 0 author

24 December 2020

Cardiac hypertrophy is a major risk factor for heart failure and leads to cardiovascular morbidity and mortality. Doxorubicin (DOX) is regarded as one of the most potent anthracycline antibiotic agents; however, its clinical usage has some limitation...

(This article belongs to the Special Issue Natural Bioactive Compounds in the Prevention and Treatment of Chronic Diseases)
  • Review
  • Open Access
34 Citations
8,298 Views
35 Pages

Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review

  • HafizMuhammad Imran,
  • Yixin Tang,
  • Siyuan Wang,
  • Xiuzhang Yan and ,
  • Chang Liu,
  • Lei Guo,
  • Erlei Wang and
  • Caina Xu
  • + 3 authors+ 0 author

20 December 2023

Chitosan nanoparticles (NPs) serve as useful multidrug delivery carriers in cancer chemotherapy. Chitosan has considerable potential in drug delivery systems (DDSs) for targeting tumor cells. Doxorubicin (DOX) has limited application due to its resis...

(This article belongs to the Special Issue Recent Advances in Nanomaterial Synthesis)
  • Article
  • Open Access
22 Citations
5,004 Views
11 Pages

Hydrogel-Mediated DOX⋅HCl/PTX Delivery System for Breast Cancer Therapy

  • Hoon Hyun,
  • Young Bum Yoo,
  • So Yeon Kim,
  • Hyun Sun Ko and ,
  • Heung Jae Chun and
  • Dae Hyeok Yang
  • + 1 author+ 0 author

20 September 2019

We used a hydrogel-mediated dual drug delivery approach, based on an injectable glycol chitosan (GC) hydrogel, doxorubicin hydrochloride (DOX⋅HCl), and a complex of beta-cyclodextrin (β-CD) and paclitaxel (PTX) (GDCP) for breast cancer therapy in vit...

(This article belongs to the Special Issue Cell-Biomaterial Interaction 2019)
  • Article
  • Open Access
28 Citations
4,396 Views
12 Pages

Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells

  • Seyedeh Tayebeh Ahmadpour,
  • Valérie Desquiret-Dumas,
  • Ulku Yikilmaz,
  • Julie Dartier and ,
  • Isabelle Domingo,
  • Celine Wetterwald,
  • Charlotte Orre,
  • Naïg Gueguen,
  • Lucie Brisson and
  • Jean-François Dumas
  • + 6 authors+ 1 author

27 August 2021

Since its discovery, mitophagy has been viewed as a protective mechanism used by cancer cells to prevent the induction of mitochondrial apoptosis. Most cancer treatments directly or indirectly cause mitochondrial dysfunction in order to trigger signa...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
6 Citations
2,129 Views
17 Pages

Self-Assembled Nanocomposite DOX/TPOR4@CB[7]4 for Enhanced Synergistic Photodynamic Therapy and Chemotherapy in Neuroblastoma

  • Zhouxia Lu,
  • Xu Chen,
  • Conghui Wang,
  • Xuelian Luo and ,
  • Xiaohan Wu,
  • Xing Zhao and
  • Song Xiao
  • + 2 authors+ 0 author

DOX/TPOR4@CB[7]4 was synthesized via self-assembly, and its physicochemical properties and ability to generate reactive oxygen species (ROS) were evaluated. The impact of photodynamic therapy on SH-SY5Y cells was assessed using the MTT assay, while f...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
9 Citations
2,624 Views
15 Pages

Effect of Nanoparticles of DOX and miR-125b on DNA Damage Repair in Glioma U251 Cells and Underlying Mechanisms

  • Lin Wang,
  • Tingting Pan,
  • Yan Wang,
  • Jiewen Yu and ,
  • Peiyi Qu,
  • Yue Chen,
  • Hua Xin,
  • Sicen Wang,
  • Junxing Liu and
  • Yan Wu
  • + 5 authors+ 0 author

21 September 2022

Glioma is the most common primary craniocerebral malignant tumor, arising from the canceration of glial cells in the brain and spinal cord. The quality of life and prognosis of patients with this disease are still poor. Doxorubicin (DOX) is one of th...

  • Article
  • Open Access
1,228 Views
13 Pages

A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules

  • Ping Sun,
  • Chunlei Gao,
  • Zhe Chen,
  • Siyu Wang and ,
  • Gang Li,
  • Mingming Luan and
  • Yaoguang Wang
  • + 2 authors+ 0 author

13 June 2025

Developing appropriate methods for real-time in situ investigation of how drugs influence signaling pathways and related biomolecules holds enormous potential for helping to provide an understanding of how anticancer drugs exert their effects. Herein...

(This article belongs to the Section Nano- and Micro-Technologies in Biosensors)
  • Article
  • Open Access
50 Citations
4,569 Views
16 Pages

Iron Oxide Nanoparticles as Carriers for DOX and Magnetic Hyperthermia after Intratumoral Application into Breast Cancer in Mice: Impact and Future Perspectives

  • Susann Piehler,
  • Heidi Dähring,
  • Julia Grandke,
  • Julia Göring and ,
  • Pierre Couleaud,
  • Antonio Aires,
  • Aitziber L. Cortajarena,
  • José Courty,
  • Alfonso Latorre and
  • Ingrid Hilger
  • + 7 authors+ 2 authors

There is still a need for improving the treatment of breast cancer with doxorubicin (DOX). In this paper, we functionalized magnetic nanoparticles (MNPs) with DOX and studied the DOX-induced antitumor effects in breast cancer cells (BT474) in the pre...

(This article belongs to the Special Issue Multi-Functional Nanoparticles for Therapy and Diagnostics)
  • Article
  • Open Access
6 Citations
2,705 Views
12 Pages

24 November 2021

Folate-aminocaproic acid-doxorubicin (FA-AMA-hyd-DOX) was firstly synthesized by our group. It was indicated that FA-AMA-hyd-DOX was pH-responsive, and had strong cytotoxicity on a folate receptor overexpressing cell line (KB cells) in vitro. The aim...

  • Article
  • Open Access
15 Citations
2,953 Views
21 Pages

Magnetoliposomes with Calcium-Doped Magnesium Ferrites Anchored in the Lipid Surface for Enhanced DOX Release

  • Beatriz D. Cardoso,
  • Diana E. M. Fernandes,
  • Carlos O. Amorim,
  • Vítor S. Amaral and ,
  • Paulo J. G. Coutinho,
  • Ana Rita O. Rodrigues and
  • Elisabete M. S. Castanheira
  • + 2 authors+ 0 author

20 September 2023

Nanotechnology has provided a new insight into cancer treatment by enabling the development of nanocarriers for the encapsulation, transport, and controlled release of antitumor drugs at the target site. Among these nanocarriers, magnetic nanosystems...

  • Article
  • Open Access
7 Citations
3,019 Views
16 Pages

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs

  • Aiwen Jiang,
  • Yangyang Ma,
  • Xue Zhang,
  • Qianqian Pan and ,
  • Pengfei Luo,
  • Hongyun Guo,
  • Wangjun Wu,
  • Juan Li,
  • Tong Yu and
  • Honglin Liu
  • + 5 authors+ 0 author

8 October 2022

Porcine-induced pluripotent stem cells (piPSCs) are of great significance to animal breeding and human medicine; however, an important problem is that the maintenance of piPSCs mainly depends on exogenous expression of pluripotent transcription facto...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Review
  • Open Access
39 Citations
6,834 Views
23 Pages

10 May 2023

Doxorubicin (DOX) is a highly effective chemotherapeutic drug, but its long-term use can cause cardiotoxicity and drug resistance. Accumulating evidence demonstrates that p53 is directly involved in DOX toxicity and resistance. One of the primary cau...

(This article belongs to the Section Phytochemicals and Human Health)
  • Article
  • Open Access
29 Citations
4,853 Views
20 Pages

24 November 2021

Cancer remains one of the leading causes of death worldwide despite extensive efforts at developing curative treatments. Chemotherapy, one of the most common forms of treatment, lacks specificity and can induce collateral damages to healthy surroundi...

(This article belongs to the Special Issue 10th Anniversary of Applied Sciences: Invited Papers in Applied Biosciences and Bioengineering Section)
  • Article
  • Open Access
16 Citations
3,553 Views
10 Pages

8 December 2022

Calcium carbonate, as the main inorganic component of human bones and teeth, has good biocompatibility and bioactivity and finds increasing applications in the field of bone drug carriers. In this study, hollow calcium carbonate microspheres were syn...

(This article belongs to the Special Issue Functional Composite Biomaterials)
  • Article
  • Open Access
8 Citations
3,569 Views
32 Pages

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold

  • Laura Braconi,
  • Chiara Riganti,
  • Astrid Parenti,
  • Marta Cecchi and ,
  • Alessio Nocentini,
  • Gianluca Bartolucci,
  • Marta Menicatti,
  • Marialessandra Contino,
  • Nicola Antonio Colabufo and
  • Elisabetta Teodori
  • + 8 authors+ 3 authors

11 July 2024

A new series of piperazine derivatives were synthesized and studied with the aim of obtaining dual inhibitors of P-glycoprotein (P-gp) and carbonic anhydrase XII (hCA XII) to synergistically overcome the P-gp-mediated multidrug resistance (MDR) in ca...

(This article belongs to the Special Issue Heterocyclic Compounds: Synthesis and Medicinal Chemistry Applications)
  • Article
  • Open Access
24 Citations
4,092 Views
17 Pages

Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells

  • Gabriel Martínez-Edo,
  • Cristina Fornaguera,
  • Salvador Borrós and
  • David Sánchez-García

A pH-triggered mesoporous silica nanoparticle (MSN)-based nano-vehicle for the dual delivery of doxorubicin (DOX)/camptothecin-PEG (CPT-PEG) has been prepared. To enhance its selectivity, the nanoparticles were decorated with glycyrrhetinic acid (GA)...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
27 Citations
4,460 Views
30 Pages

Harnessing Folate-Functionalized Nasal Delivery of Dox–Erlo-Loaded Biopolymeric Nanoparticles in Cancer Treatment: Development, Optimization, Characterization, and Biodistribution Analysis

  • Ms Farheen,
  • Md Habban Akhter,
  • Havagiray Chitme,
  • Md Sayeed Akhter and ,
  • Fauzia Tabassum,
  • Mariusz Jaremko and
  • Abdul-Hamid Emwas
  • + 2 authors+ 0 author

30 January 2023

The aim of the present study is to develop Doxorubicin–Erlotinib nanoparticles (Dox–Erlo NPs) and folate-armored Dox–Erlo-NP conjugates for targeting glioma cancer. Glioma is one of the most common progressive cancerous growths orig...

(This article belongs to the Special Issue Recent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment)
  • Article
  • Open Access
20 Citations
6,449 Views
14 Pages

4 February 2016

Multidrug resistance (MDR) is a prime reason for numerous failed oncotherapy approaches. In the present study, we investigated whether Alisol F 24 acetate (ALI) could reverse the MDR of MCF-7/DOX cells, a multidrug-resistant human breast cancer cell...

(This article belongs to the Special Issue New Approaches to Counteract Drug Resistance in Cancer)
  • Feature Paper
  • Article
  • Open Access
42 Citations
5,267 Views
26 Pages

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells

  • Elisabetta Teodori,
  • Laura Braconi,
  • Silvia Bua,
  • Andrea Lapucci and ,
  • Gianluca Bartolucci,
  • Dina Manetti,
  • Maria Novella Romanelli,
  • Silvia Dei,
  • Claudiu T. Supuran and
  • Marcella Coronnello
  • + 5 authors+ 0 author

10 April 2020

A new series of N,N-bis(alkanol)amine aryl diesters was synthesized and studied as dual P-glycoprotein (P-gp) and carbonic anhydrase XII inhibitors (CA XII). These hybrids should be able to synergistically overcome P-gp mediated multidrug resistance...

(This article belongs to the Special Issue Multitarget Ligands)
  • Article
  • Open Access
12 Citations
5,939 Views
13 Pages

Protein-based nanoparticles, as an alternative to conventional polymer-based nanoparticles, offer great advantages in biomedical applications owing to their functional and biocompatible characteristics. However, the route of fabrication towards prote...

(This article belongs to the Special Issue Protein Nanostructures for Biomedical Applications)
  • Article
  • Open Access
2 Citations
3,096 Views
18 Pages

Revealing the interaction mechanisms between anticancer drugs and target DNA molecules at the single-molecule level is a hot research topic in the interdisciplinary fields of biophysical chemistry and pharmaceutical engineering. When fluorescence ima...

(This article belongs to the Section Molecular Biophysics)
  • Article
  • Open Access
16 Citations
6,369 Views
27 Pages

Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells

  • Chhanda Bose,
  • Ashly Hindle,
  • Jihyun Lee,
  • Jonathan Kopel and ,
  • Sahil Tonk,
  • Philip T. Palade,
  • Sharad S. Singhal,
  • Sanjay Awasthi and
  • Sharda P. Singh
  • + 4 authors+ 0 author

20 December 2021

Her2-amplified breast cancers resistant to available Her2-targeted therapeutics continue to be a challenge in breast cancer therapy. Dox is the mainstay of chemotherapy of all types of breast cancer, but its usefulness is limited by cumulative cardio...

(This article belongs to the Special Issue p53 and Ralbp1 in Carcinogenesis)
  • Article
  • Open Access
48 Citations
7,088 Views
11 Pages

Optical Properties of Doxorubicin Hydrochloride Load and Release on Silica Nanoparticle Platform

  • Trong Nghia Nguyen,
  • Thi Thuy Nguyen,
  • Thi Ha Lien Nghiem,
  • Duc Toan Nguyen and ,
  • Thi Thu Ha Tran,
  • Duong Vu,
  • Thi Bich Ngoc Nguyen,
  • Thi Minh Huyen Nguyen,
  • Van Tien Nguyen and
  • Minh Hue Nguyen
  • + 5 authors+ 0 author

29 June 2021

Silica nanoparticles (SiO2 NPs) synthesized by the Stober method were used as drug delivery vehicles. Doxorubicin hydrochloride (DOX·HCl) is a chemo-drug absorbed onto the SiO2 NPs surfaces. The DOX·HCl loading onto and release from the SiO2 NPs was...

(This article belongs to the Special Issue Nanomaterials for Biomedical Application)
  • Article
  • Open Access
30 Citations
3,718 Views
14 Pages

The Ameliorative Effect of Pioglitazone against Neuroinflammation Caused by Doxorubicin in Rats

  • May M. Alsaud,
  • Ahmad H. Alhowail,
  • Maha A. Aldubayan and
  • Ibtesam S. Almami

15 June 2023

Doxorubicin (DOX) is a chemotherapeutic agent that is linked with complications such as cardiotoxicity and cognitive dysfunction, known as chemobrain. Chemobrain affects up to 75% of cancer survivors, and there are no known therapeutic options for it...

(This article belongs to the Special Issue Bioactive Compounds for Brain Ischemia and Neurodegenerative Disease)
  • Article
  • Open Access
7 Citations
3,108 Views
15 Pages

27 February 2024

Pigment epithelium-derived factor (PEDF), a serine protease inhibitor (Serpin) family member, shows promise in inhibiting tumour growth. In our study, we explored the effects of PEDF on the efficacy of the frontline chemotherapy agent doxorubicin (Do...

(This article belongs to the Special Issue Molecular Advances in Cancer and Cell Metabolism)
  • Article
  • Open Access
7 Citations
6,862 Views
23 Pages

Brief Magnetic Field Exposure Stimulates Doxorubicin Uptake into Breast Cancer Cells in Association with TRPC1 Expression: A Precision Oncology Methodology to Enhance Chemotherapeutic Outcome

  • Viresh Krishnan Sukumar,
  • Yee Kit Tai,
  • Ching Wan Chan,
  • Jan Nikolas Iversen and ,
  • Kwan Yu Wu,
  • Charlene Hui Hua Fong,
  • Joline Si Jing Lim and
  • Alfredo Franco-Obregón
  • + 3 authors+ 0 author

18 November 2024

Background/Objectives: Doxorubicin (DOX) is commonly used as a chemotherapeutic agent for the treatment of breast cancer. Nonetheless, its systemic delivery via intravenous injection and toxicity towards healthy tissues commonly result in a broad ran...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
100 Citations
8,582 Views
15 Pages

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2

  • Zhongyi Tong,
  • Bimei Jiang,
  • Yanyang Wu,
  • Yanjuan Liu and ,
  • Yuanbin Li,
  • Min Gao,
  • Yu Jiang,
  • Qinglan Lv and
  • Xianzhong Xiao
  • + 4 authors+ 0 author

26 June 2015

Doxorubicin (DOX) is an anthracycline drug with a wide spectrum of antineoplastic activities. However, it causes cardiac cytotoxicity, and this limits its clinical applications. MicroRNA-21 (miR-21) plays a vital role in regulating cell proliferation...

(This article belongs to the Special Issue Improvement of Cardiac Function in Heart Failure)
  • Review
  • Open Access
128 Citations
23,246 Views
32 Pages

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histo...

(This article belongs to the Special Issue Feature Reviews in Pharmaceutical Technology)
  • Article
  • Open Access
10 Citations
2,983 Views
15 Pages

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy

  • Yanyan Ma,
  • Jipeng Ma,
  • Linhe Lu,
  • Xiang Xiong and ,
  • Yalan Shao,
  • Jun Ren,
  • Jian Yang and
  • Jiankang Liu
  • + 3 authors+ 0 author

4 September 2023

Doxorubicin (DOX) chemotherapy in cancer patients increases the risk of the occurrence of cardiac dysfunction and even results in congestive heart failure. Despite the great progress of pathology in DOX-induced cardiomyopathy, the underlying molecula...

(This article belongs to the Special Issue The 10th Anniversary of Antioxidants: Past, Present and Future)
  • Article
  • Open Access
6 Citations
2,681 Views
12 Pages

Cancer cells’ resistance to anticancer drugs represents a major clinical problem and the most important failure of treatment. Combination chemotherapy is more effective than monotherapy due to additive or synergistic effects. The aim of our res...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Review
  • Open Access
92 Citations
9,181 Views
16 Pages

Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay

  • Leonardo Schirone,
  • Luca D’Ambrosio,
  • Maurizio Forte,
  • Riccardo Genovese and ,
  • Sonia Schiavon,
  • Giulia Spinosa,
  • Giuliano Iacovone,
  • Valentina Valenti,
  • Giacomo Frati and
  • Sebastiano Sciarretta
  • + 5 authors+ 0 author

22 June 2022

Cardiotoxicity has emerged as a major side effect of doxorubicin (DOX) treatment, affecting nearly 30% of patients within 5 years after chemotherapy. Heart failure is the first non-cancer cause of death in DOX-treated patients. Although many differen...

(This article belongs to the Special Issue Cardiac Growth Control and Heart Cell Death)
  • Feature Paper
  • Article
  • Open Access
30 Citations
6,447 Views
23 Pages

Synthesis and Anti-Melanoma Activity of L-Cysteine-Coated Iron Oxide Nanoparticles Loaded with Doxorubicin

  • Luiza Izabela Toderascu,
  • Livia Elena Sima,
  • Stefana Orobeti,
  • Paula Ecaterina Florian and ,
  • Madalina Icriverzi,
  • Valentin-Adrian Maraloiu,
  • Cezar Comanescu,
  • Nicusor Iacob,
  • Victor Kuncser and
  • Gabriel Socol
  • + 10 authors+ 5 authors

4 February 2023

In this study, we report on the synthesis of L-Cysteine (L-Cys)-coated magnetic iron oxide nanoparticles (NPs) loaded with doxorubicin (Dox). The Fe3O4-L-Cys-Dox NPs were extensively characterized for their compositional and morpho-structural feature...

(This article belongs to the Special Issue Thin Films Based on Nanocomposites (2nd Edition))
  • Article
  • Open Access
9 Citations
2,836 Views
15 Pages

Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment

  • Xiao Mi,
  • Yang Lou,
  • Yutian Wang,
  • Mingran Dong and ,
  • Hongwei Xue,
  • Shuyang Li,
  • Juan Lu and
  • Xi Chen
  • + 3 authors+ 0 author

16 December 2023

In this study, we designed and developed a DOX nanodrug delivery system (PEG-GA@ZIF-8@DOX) using ZIF-8 as the carrier and glycyrrhetinic acid (GA) as the targeting ligand. We confirmed that DOX was loaded and PEG-GA was successfully modified on the s...

  • Feature Paper
  • Article
  • Open Access
8 Citations
5,702 Views
15 Pages

5 January 2022

Combinational therapy using chemodynamictherapy (CDT) and photothermal therapy (PTT) is known to enhance the therapeutic outcome for cancer treatment. In this study, a biocompatible nano formulation was developed by coating polydopamine (PDA) over do...

(This article belongs to the Special Issue Advances in Nanoparticles: Surface Modification, Characterization and Its Application)
  • Article
  • Open Access
6 Citations
3,052 Views
11 Pages

17 July 2024

Doxorubicin (DOX) has been an effective antitumor agent for human liver cancer cells; however, an overdose might lead to major side effects appearing in clinical applications. In this work, we present a strategy of combining DOX and blue light (BL) i...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
18 Citations
6,609 Views
14 Pages

The role of the epidermal growth factor receptor (EGFR) in tumor progression and survival is often underplayed. Its expression and/or dysregulation is associated with disease advancement and poor patient outcome as well as drug resistance in breast c...

(This article belongs to the Section Molecular Oncology)

of 29